The inflammasome NLRP12 is associated with both depression and coronary artery disease in Vietnam veterans

[1]  R. Young,et al.  The association between post-traumatic stress disorder and coronary artery disease: a meta-analysis , 2018, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[2]  R. Young,et al.  PTSD symptoms associated with myocardial infarction: practical clinical implications , 2018, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[3]  R. Harrington.  Targeting Inflammation in Coronary Artery Disease. , 2017, The New England journal of medicine.

[4]  C. P. Morris,et al.  Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience. , 2017, Gene.

[5]  D. Agrawal,et al.  The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques. , 2017, Canadian journal of physiology and pharmacology.

[6]  O. Tawfik,et al.  Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer , 2017, Scientific Reports.

[7]  N. Zmora,et al.  Inflammasomes and intestinal inflammation , 2017, Mucosal Immunology.

[8]  R. Young,et al.  Physical comorbidities of post‐traumatic stress disorder in Australian Vietnam War veterans , 2017, The Medical journal of Australia.

[9]  O. Wolkowitz,et al.  Oxidative stress, inflammation and treatment response in major depression , 2017, Psychoneuroendocrinology.

[10]  Wenfei Huang,et al.  NLRP12 Inflammasome Expression in the Rat Brain in Response to LPS during Morphine Tolerance , 2017, Brain sciences.

[11]  M. Cordero,et al.  NLRP3 inflammasome: common nexus between depression and cardiovascular diseases , 2017, Nature Reviews Cardiology.

[12]  Kashif Asghar,et al.  Role of inflammatory cytokines in depression: Focus on interleukin-1β. , 2017, Biomedical reports.

[13]  P. Stang,et al.  Depression Is Associated With High Levels of C-Reactive Protein and Low Levels of Fractional Exhaled Nitric Oxide: Results From the 2007-2012 National Health and Nutrition Examination Surveys. , 2016, The Journal of clinical psychiatry.

[14]  K. Jellinger,et al.  Vascular depression consensus report – a critical update , 2016, BMC Medicine.

[15]  D. Jacobowitz,et al.  “Soldier's Heart”: A Genetic Basis for Elevated Cardiovascular Disease Risk Associated with Post-traumatic Stress Disorder , 2016, Front. Mol. Neurosci..

[16]  V. Pavlov,et al.  PTSD, a Disorder with an Immunological Component , 2016, Front. Immunol..

[17]  P. Eriksson,et al.  NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis , 2016, Journal of the American Heart Association.

[18]  Ming Lu,et al.  Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression , 2016, The international journal of neuropsychopharmacology.

[19]  M. Whooley,et al.  Direction of Association Between Depressive Symptoms and Lifestyle Behaviors in Patients with Coronary Heart Disease: the Heart and Soul Study , 2016, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[20]  M. Sayan,et al.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases , 2015, Particle and Fibre Toxicology.

[21]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[22]  H. Jacob,et al.  SH2B3 Is a Genetic Determinant of Cardiac Inflammation and Fibrosis , 2015, Circulation. Cardiovascular genetics.

[23]  A. Verma,et al.  Oxidative stress and major depression. , 2014, Journal of clinical and diagnostic research : JCDR.

[24]  M. Cordero,et al.  NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder , 2014, Brain, Behavior, and Immunity.

[25]  C. Power,et al.  Inflammasomes in the CNS , 2014, Nature Reviews Neuroscience.

[26]  Klaus P. Ebmeier,et al.  CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. , 2013, Journal of affective disorders.

[27]  E. Latz,et al.  Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.

[28]  M. Sosa,et al.  Asociación entre depresión y niveles altos de glucosa en pacientes mexicanos de edad media con diabetes , 2013 .

[29]  B. Bradley,et al.  Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder , 2013, Proceedings of the National Academy of Sciences.

[30]  C. Kȩpka,et al.  What is the optimal cut-off point for low coronary artery calcium score assessed by computed tomography? Multi-Detector Computed Tomography ANIN Registry , 2013, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

[31]  Z. Motovska,et al.  Oxidative stress: Predictive marker for coronary artery disease. , 2013, Experimental and clinical cardiology.

[32]  M. Hernández-González,et al.  Association between depression and higher glucose levels in middle-aged Mexican patients with diabetes. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[33]  Amit Anand,et al.  Where in the Brain Is Depression? , 2012, Current Psychiatry Reports.

[34]  Lili Yu,et al.  Low cholesterol is associated with depression among US household population. , 2011, Journal of affective disorders.

[35]  C. Heim,et al.  A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities , 2011, Brain, Behavior, and Immunity.

[36]  Wei Shi,et al.  Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips , 2010, Nucleic acids research.

[37]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[38]  J. McAuley,et al.  The Depression Anxiety Stress Scale (DASS). , 2010, Journal of physiotherapy.

[39]  J. Westermeyer,et al.  Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. , 2009, Psychiatry (Edgmont (Pa. : Township)).

[40]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[41]  Tom R. Gaunt,et al.  American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .

[42]  John D. Storey,et al.  Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis , 2007, PLoS genetics.

[43]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[44]  Peter Herscovitch,et al.  Regional cerebral glucose utilization in patients with a range of severities of unipolar depression , 2002, Biological Psychiatry.

[45]  M. Maes.  Interleukin‐1β and the etiology of depression , 2001, Acta psychiatrica Scandinavica.

[46]  D. Crossman,et al.  Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[47]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[48]  P. Lovibond,et al.  The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. , 1995, Behaviour research and therapy.

[49]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.